Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinopathy of Prematurity | 11 | 2024 | 450 | 2.550 |
Why?
|
Visual Acuity | 15 | 2024 | 2714 | 2.180 |
Why?
|
Retinal Perforations | 4 | 2024 | 138 | 1.750 |
Why?
|
Fluorescein Angiography | 9 | 2024 | 1086 | 1.410 |
Why?
|
Coloboma | 2 | 2024 | 60 | 1.350 |
Why?
|
Retinal Detachment | 5 | 2024 | 429 | 1.330 |
Why?
|
Vitrectomy | 7 | 2024 | 392 | 1.240 |
Why?
|
Tomography, Optical Coherence | 10 | 2024 | 2937 | 1.070 |
Why?
|
Intravitreal Injections | 7 | 2024 | 402 | 1.060 |
Why?
|
Fovea Centralis | 2 | 2024 | 126 | 0.970 |
Why?
|
Posterior Eye Segment | 1 | 2024 | 18 | 0.940 |
Why?
|
Pentosan Sulfuric Polyester | 1 | 2024 | 11 | 0.940 |
Why?
|
Albinism, Oculocutaneous | 1 | 2024 | 19 | 0.920 |
Why?
|
Lenses, Intraocular | 2 | 2023 | 141 | 0.920 |
Why?
|
Nystagmus, Pathologic | 1 | 2024 | 104 | 0.850 |
Why?
|
Cataract | 2 | 2025 | 837 | 0.850 |
Why?
|
Eye Injuries, Penetrating | 1 | 2024 | 121 | 0.790 |
Why?
|
Phacoemulsification | 1 | 2023 | 151 | 0.730 |
Why?
|
Angiogenesis Inhibitors | 8 | 2024 | 2057 | 0.720 |
Why?
|
Retinal Diseases | 2 | 2024 | 709 | 0.690 |
Why?
|
Retinal Vessels | 3 | 2024 | 863 | 0.660 |
Why?
|
Regional Blood Flow | 1 | 2023 | 1478 | 0.650 |
Why?
|
Keratoconus | 1 | 2020 | 112 | 0.620 |
Why?
|
Eye Neoplasms | 1 | 2020 | 305 | 0.620 |
Why?
|
Dry Eye Syndromes | 1 | 2022 | 385 | 0.590 |
Why?
|
Retina | 5 | 2023 | 2660 | 0.560 |
Why?
|
Orbital Diseases | 1 | 2019 | 178 | 0.560 |
Why?
|
Retinal Artery Occlusion | 2 | 2024 | 83 | 0.550 |
Why?
|
Retinal Degeneration | 2 | 2024 | 413 | 0.490 |
Why?
|
Silicone Oils | 1 | 2024 | 22 | 0.470 |
Why?
|
Kearns-Sayre Syndrome | 1 | 2024 | 6 | 0.470 |
Why?
|
Endotamponade | 1 | 2024 | 37 | 0.460 |
Why?
|
Vitreous Hemorrhage | 1 | 2024 | 47 | 0.460 |
Why?
|
Photochemotherapy | 1 | 2020 | 828 | 0.450 |
Why?
|
Triamcinolone Acetonide | 1 | 2025 | 105 | 0.450 |
Why?
|
Lens Subluxation | 1 | 2024 | 23 | 0.450 |
Why?
|
Retinal Hemorrhage | 1 | 2024 | 98 | 0.440 |
Why?
|
Histiocytic Necrotizing Lymphadenitis | 1 | 2024 | 27 | 0.440 |
Why?
|
Recovery of Function | 1 | 2024 | 2976 | 0.440 |
Why?
|
Vascular Endothelial Growth Factor A | 6 | 2024 | 3511 | 0.440 |
Why?
|
Retinal Vasculitis | 1 | 2024 | 46 | 0.440 |
Why?
|
Vitreous Detachment | 1 | 2023 | 23 | 0.430 |
Why?
|
Eye Diseases | 1 | 2019 | 660 | 0.430 |
Why?
|
Retinoschisis | 1 | 2023 | 30 | 0.430 |
Why?
|
Sickle Cell Trait | 1 | 2024 | 86 | 0.430 |
Why?
|
Ocular Hypertension | 1 | 2025 | 211 | 0.420 |
Why?
|
Hemangioblastoma | 1 | 2022 | 62 | 0.390 |
Why?
|
Wet Macular Degeneration | 1 | 2024 | 165 | 0.390 |
Why?
|
Lens, Crystalline | 1 | 2024 | 387 | 0.380 |
Why?
|
Endophthalmitis | 1 | 2024 | 263 | 0.380 |
Why?
|
Eye Infections, Bacterial | 1 | 2024 | 239 | 0.380 |
Why?
|
Choroid | 1 | 2024 | 364 | 0.370 |
Why?
|
Myasthenia Gravis | 1 | 2024 | 214 | 0.370 |
Why?
|
von Hippel-Lindau Disease | 1 | 2022 | 154 | 0.370 |
Why?
|
Turner Syndrome | 1 | 2022 | 129 | 0.370 |
Why?
|
Myopia | 1 | 2024 | 254 | 0.370 |
Why?
|
Retinal Neovascularization | 1 | 2024 | 287 | 0.360 |
Why?
|
Retinal Neoplasms | 1 | 2022 | 151 | 0.350 |
Why?
|
Choroidal Neovascularization | 1 | 2024 | 364 | 0.350 |
Why?
|
Cataract Extraction | 1 | 2024 | 464 | 0.340 |
Why?
|
Intraocular Pressure | 1 | 2025 | 1304 | 0.310 |
Why?
|
Glucocorticoids | 2 | 2025 | 2158 | 0.300 |
Why?
|
Fundus Oculi | 3 | 2024 | 560 | 0.300 |
Why?
|
Fluorocarbons | 1 | 2023 | 498 | 0.300 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2823 | 0.290 |
Why?
|
Retrospective Studies | 19 | 2025 | 81635 | 0.290 |
Why?
|
Gestational Age | 6 | 2024 | 3617 | 0.280 |
Why?
|
Infant, Premature | 5 | 2024 | 2120 | 0.280 |
Why?
|
Laser Coagulation | 2 | 2024 | 335 | 0.280 |
Why?
|
Infant, Newborn | 12 | 2024 | 26389 | 0.270 |
Why?
|
Nystagmus, Congenital | 1 | 2024 | 9 | 0.230 |
Why?
|
Humans | 44 | 2025 | 766766 | 0.230 |
Why?
|
CHARGE Syndrome | 1 | 2024 | 34 | 0.230 |
Why?
|
Cystitis, Interstitial | 1 | 2024 | 68 | 0.230 |
Why?
|
Scleral Buckling | 2 | 2024 | 95 | 0.220 |
Why?
|
Geographic Atrophy | 1 | 2024 | 92 | 0.210 |
Why?
|
Axial Length, Eye | 1 | 2023 | 36 | 0.210 |
Why?
|
Eye Diseases, Hereditary | 1 | 2024 | 124 | 0.210 |
Why?
|
Aicardi Syndrome | 1 | 2023 | 16 | 0.210 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5690 | 0.210 |
Why?
|
Meibomian Glands | 1 | 2022 | 74 | 0.200 |
Why?
|
Scleral Diseases | 1 | 2022 | 22 | 0.200 |
Why?
|
Melanoma | 1 | 2020 | 5700 | 0.190 |
Why?
|
Refraction, Ocular | 1 | 2023 | 188 | 0.190 |
Why?
|
Optics and Photonics | 1 | 2023 | 305 | 0.180 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5861 | 0.180 |
Why?
|
Lens Implantation, Intraocular | 1 | 2022 | 192 | 0.180 |
Why?
|
Corneal Topography | 1 | 2020 | 69 | 0.180 |
Why?
|
Riboflavin | 1 | 2020 | 106 | 0.170 |
Why?
|
Blindness | 1 | 2024 | 585 | 0.170 |
Why?
|
Infant | 7 | 2025 | 36461 | 0.160 |
Why?
|
Biometry | 1 | 2023 | 571 | 0.160 |
Why?
|
Neonatal Screening | 3 | 2024 | 619 | 0.160 |
Why?
|
Spasms, Infantile | 1 | 2023 | 300 | 0.160 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3446 | 0.160 |
Why?
|
Membrane Transport Proteins | 1 | 2024 | 1029 | 0.150 |
Why?
|
Atrophy | 2 | 2024 | 1631 | 0.150 |
Why?
|
Child | 9 | 2025 | 80668 | 0.150 |
Why?
|
Cross-Linking Reagents | 1 | 2020 | 689 | 0.140 |
Why?
|
Male | 19 | 2025 | 364142 | 0.140 |
Why?
|
Heterozygote | 1 | 2024 | 2795 | 0.140 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2024 | 858 | 0.140 |
Why?
|
Female | 18 | 2025 | 396520 | 0.140 |
Why?
|
Infant, Newborn, Diseases | 1 | 2022 | 587 | 0.140 |
Why?
|
Cysts | 1 | 2022 | 685 | 0.140 |
Why?
|
Photosensitizing Agents | 1 | 2020 | 627 | 0.130 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13643 | 0.130 |
Why?
|
Follow-Up Studies | 4 | 2025 | 39309 | 0.130 |
Why?
|
Adolescent | 6 | 2025 | 88904 | 0.130 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1101 | 0.120 |
Why?
|
Tenon Capsule | 1 | 2025 | 6 | 0.120 |
Why?
|
Birth Weight | 4 | 2024 | 2123 | 0.120 |
Why?
|
Injections, Intraocular | 1 | 2025 | 36 | 0.120 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1063 | 0.120 |
Why?
|
Propionibacteriaceae | 1 | 2024 | 10 | 0.120 |
Why?
|
Anisocoria | 1 | 2024 | 9 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 12985 | 0.110 |
Why?
|
Disease Management | 2 | 2024 | 2533 | 0.110 |
Why?
|
Macula Lutea | 1 | 2024 | 180 | 0.100 |
Why?
|
Collagen | 1 | 2020 | 2635 | 0.100 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2024 | 340 | 0.100 |
Why?
|
Dissection | 1 | 2023 | 298 | 0.100 |
Why?
|
Patient Positioning | 1 | 2024 | 332 | 0.100 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2662 | 0.090 |
Why?
|
Sclera | 2 | 2022 | 189 | 0.090 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5536 | 0.090 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2024 | 354 | 0.090 |
Why?
|
Academic Medical Centers | 2 | 2024 | 2783 | 0.080 |
Why?
|
Child, Preschool | 3 | 2025 | 42577 | 0.080 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2024 | 452 | 0.080 |
Why?
|
Capillaries | 1 | 2022 | 755 | 0.080 |
Why?
|
X Chromosome | 1 | 2022 | 819 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 872 | 0.080 |
Why?
|
Aged | 5 | 2024 | 171343 | 0.080 |
Why?
|
Treatment Outcome | 4 | 2024 | 65273 | 0.070 |
Why?
|
Young Adult | 2 | 2024 | 59939 | 0.070 |
Why?
|
Algorithms | 2 | 2024 | 14072 | 0.070 |
Why?
|
Middle Aged | 6 | 2024 | 223257 | 0.060 |
Why?
|
Reoperation | 1 | 2024 | 4325 | 0.060 |
Why?
|
Adult | 5 | 2024 | 223307 | 0.060 |
Why?
|
Acute Disease | 1 | 2024 | 7241 | 0.050 |
Why?
|
Vigabatrin | 1 | 2023 | 88 | 0.050 |
Why?
|
Recurrence | 1 | 2024 | 8507 | 0.050 |
Why?
|
Incidence | 2 | 2025 | 21525 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 13476 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2022 | 748 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5387 | 0.040 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2023 | 409 | 0.040 |
Why?
|
Mutation | 1 | 2024 | 30213 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2022 | 870 | 0.040 |
Why?
|
Ophthalmology | 1 | 2024 | 560 | 0.040 |
Why?
|
Vision Disorders | 1 | 2023 | 1090 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7475 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13485 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59550 | 0.030 |
Why?
|
Phenotype | 1 | 2022 | 16724 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2023 | 1921 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2024 | 15831 | 0.020 |
Why?
|
Cohort Studies | 1 | 2024 | 41710 | 0.020 |
Why?
|
Risk Factors | 2 | 2023 | 74881 | 0.020 |
Why?
|
United States | 2 | 2024 | 72951 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9244 | 0.020 |
Why?
|
Concepts
(162)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_